After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, EXAS falls under the Healthcare sector while operating within the Diagnostics & Research industry segment. The current market capitalization of Exact Sciences Corp is $10.20B. A total of 3.54 million shares were traded on the day, compared to an average of 2.63M shares.
In the most recent transaction, Conroy Kevin T bought 19,500 shares of EXAS for 51.35 per share on Nov 13 ’24. After the transaction, the President and CEO now owns 1,074,191 company shares. In a previous transaction on Oct 08 ’24, Baranick Brian sold 929 shares at 70.00 per share. EXAS shares that EVP, GM, Precision Oncology owns now total 12,758.
Among the insiders who bought shares, Baranick Brian acquired of 929 shares on Oct 08 ’24 at a per-share price of $70.00. In another insider transaction, Baranick Brian sold 929 shares at $70.00 per share on Sep 18 ’24. Company shares held by the EVP, GM, Precision Oncology now total 13,687.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, EXAS has a high of $79.62 and a low of $40.62.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. EXAS’s latest balance sheet shows that the firm has $1.03B in Cash & Short Term Investments as of fiscal 2021. There were $2.38B in debt and $517.07M in liabilities at the time. Its Book Value Per Share was $17.35, while its Total Shareholder’s Equity was $3.39B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXAS is Buy with a score of 4.82.